161 related articles for article (PubMed ID: 34121248)
21. First report of the rare RhCE-depleted D--phenotype in sixteen people of Iranian origin.
Shahverdi E; Moghaddam M; Abolghasemi H
Vox Sang; 2019 Apr; 114(3):256-261. PubMed ID: 30784072
[TBL] [Abstract][Full Text] [Related]
22. Molecular basis of the rare gene complex, DIVa(C)-, which encodes four low-prevalence antigens in the Rh blood group system.
Hipsky CH; Hue-Roye K; Lomas-Francis C; Huang CH; Reid ME
Vox Sang; 2012 Feb; 102(2):167-70. PubMed ID: 21729099
[TBL] [Abstract][Full Text] [Related]
23. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
Roubalová L; Lubušký M
Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive approach for the management of hemolytic disease of the fetus.
Illanes S; Soothill P
Expert Rev Hematol; 2009 Oct; 2(5):577-82. PubMed ID: 21083022
[TBL] [Abstract][Full Text] [Related]
25. RHD and RHCE molecular analysis in weak D blood donors and in patients with Rh antibodies against their own corresponding Rh antigen.
Souza Silva TC; Cruz BR; Costa SS; Chiba AK; Barros MMO; Langhi DM; Bordin JO
Blood Transfus; 2020 Jul; 18(4):295-303. PubMed ID: 32697929
[TBL] [Abstract][Full Text] [Related]
26. Clinical aspects of Rh genotyping.
Cotorruelo CM; Biondi CS; García Borrás S; Racca AL
Clin Lab; 2002; 48(5-6):271-81. PubMed ID: 12071577
[TBL] [Abstract][Full Text] [Related]
27. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
[TBL] [Abstract][Full Text] [Related]
28. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
29. A case report of haemolytic disease of the foetus and newborn caused by Alloantibody D and Jka in a Rhesus D negative Nigerian woman: Justification for the implementation of universal access to prophylaxis and evidenced-based best practices.
Erhabor O; Azachi WB; Tosan E
Hum Antibodies; 2020; 28(3):245-252. PubMed ID: 32417769
[TBL] [Abstract][Full Text] [Related]
30. Hemolytic disease of the fetus and newborn in the molecular era.
Fasano RM
Semin Fetal Neonatal Med; 2016 Feb; 21(1):28-34. PubMed ID: 26589360
[TBL] [Abstract][Full Text] [Related]
31. A Guide to Terminology for Rh Immunoprophylaxis.
Sandler SG; Queenan JT
Obstet Gynecol; 2017 Sep; 130(3):633-635. PubMed ID: 28796682
[TBL] [Abstract][Full Text] [Related]
32. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
Delaney M; Matthews DC
Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
[TBL] [Abstract][Full Text] [Related]
33. RhD status of a fetus at risk for haemolytic disease with a discrepant maternal DNA-based RhD genotype.
Denomme GA; Akoury H; Sermer M; Kelton JG
Prenat Diagn; 1999 May; 19(5):424-7. PubMed ID: 10360510
[TBL] [Abstract][Full Text] [Related]
34. [Genotyping for Auxiliary Identification of Anti-C Alloantibody with Anti-f Autoantibody Mimicking Alloantibody].
Kong YK; Yang QK; Cai XH; Song J; Shao M; Wang J; Wang L; Lyu XP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1740-1745. PubMed ID: 33067983
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetics of RH and its clinical application.
Flegel WA
Transfus Clin Biol; 2006; 13(1-2):4-12. PubMed ID: 16563832
[TBL] [Abstract][Full Text] [Related]
36. Determination of fetal RHD type in plasma of RhD negative pregnant women.
Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
[TBL] [Abstract][Full Text] [Related]
37. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of a rare Rh phenotype Dc-from the Indian subcontinent.
Afroz T; Mishra G; Saleh AJM; Madkaikar M; Kulkarni S
Transfus Apher Sci; 2021 Jun; 60(3):103109. PubMed ID: 33752990
[TBL] [Abstract][Full Text] [Related]
39. Hemolytic disease of the fetus and newborn caused by anti-s
Lopez GH; Emthip M; Suwanwootichai P; Millard GM; Wilson B; Onpuns S; Laemsri K; Chiewsilp P; Flower RL; Hyland CA; Liew YW
Transfusion; 2022 Oct; 62(10):2137-2142. PubMed ID: 36062546
[TBL] [Abstract][Full Text] [Related]
40. Neonatal haemolytic disease with co-existing Anti-D and Anti-C antibodies.
Durrani HM; Zaman Z; Raza IM; Jamali M; Saleem A; Ejaz SM
J Pak Med Assoc; 2022 Nov; 72(11):2320-2322. PubMed ID: 37013314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
